WA
LH icon

Whipplewood Advisors’s Labcorp LH Stock Holding History

Whipplewood Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$1.87K – 880
2026
Q1 		$1.87K Buy
7
+3
+75% +$812 ﹤0.01% 777
2025
Q4 		$1K Buy
+4
New +$1.06K ﹤0.01% 412
2025
Q3 		– Sell
-13
Closed -$3.41K – 786
2025
Q2 		$3.41K Sell
13
-44
-77% -$10.7K ﹤0.01% 772
2025
Q1 		$3.02K Buy
57
+46
+418% +$11.2K ﹤0.01% 804
2024
Q4 		$2.52K Buy
+11
New +$2.52K ﹤0.01% 829

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Whipplewood Advisors's LH Position: Q2 2026 in Review

Whipplewood Advisors sold out of Labcorp (LH) in Q2 2026, closing a stake of 7 shares — an estimated $1.87K sold.

Whipplewood Advisors first reported a position in LH in Q4 2024 and held it in 5 quarters. The position peaked at $3.41K in Q2 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Whipplewood Advisors reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Whipplewood Advisors sold 7 Labcorp shares in Q2 2026, an estimated $1.87K.
  • Whipplewood Advisors first reported a position in Labcorp in Q4 2024 and held it in 5 quarters.
  • Whipplewood Advisors's Labcorp position peaked at $3.41K in Q2 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.